Insiders · Profile

Mostafa Adam S.

Chief Financial Officer at X4 Pharmaceuticals. Filing since 30 Jun 2020. CIK 0001738081

Company
Date
Role
Action
Shares
Amount
Of holding
24 Jan 2025
Chief Financial Officer
Sold at will
74,773
$33.95K
100%
7 Oct 2024
Chief Financial Officer
Sold at will
230,645
$126.90K
100%
11 Mar 2024
Chief Financial Officer
Sold at will
52,500
$46.35K
100%
12 Feb 2024
Chief Financial Officer
Sold at will
27,721
$27.97K
34.6%
1 Nov 2023
Chief Financial Officer
Sold on a plan
230,645
$168.37K
74.2%
30 Jun 2023
Chief Financial Officer
Sold at will
2,641
$4.99K
3.2%
23 Jun 2023
Chief Financial Officer
Sold at will
5,417
$10.45K
6.1%
15 Jun 2023
Chief Financial Officer
Sold at will
5,417
$12.03K
5.8%
10 Mar 2023
Chief Financial Officer
Sold, plan not stated
52,500
$44.10K
35.9%
13 Feb 2023
Chief Financial Officer
Sold, plan not stated
27,721
$25.78K
15.9%
17 Aug 2022
Chief Financial Officer
Sold, plan not stated
10,834
no price
5.9%
30 Jun 2022
Chief Financial Officer
Sold, plan not stated
2,641
no price
1.4%
24 Jun 2022
Chief Financial Officer
Sold, plan not stated
5,416
no price
2.8%
16 Jun 2022
Chief Financial Officer
Sold, plan not stated
5,416
no price
2.7%
11 Feb 2022
Chief Financial Officer
Sold, plan not stated
27,721
no price
22.9%
17 Aug 2021
Chief Financial Officer
Sold, plan not stated
10,832
$55.24K
8.2%
30 Jun 2021
Chief Financial Officer
Sold, plan not stated
2,641
$17.54K
2.0%
24 Jun 2021
Chief Financial Officer
Sold, plan not stated
5,417
$37.97K
3.9%
15 Jun 2021
Chief Financial Officer
Sold, plan not stated
5,417
$42.47K
4.2%
21 Sep 2020
Chief Financial Officer
Sold, plan not stated
10,834
$76.70K
26.8%
30 Jun 2020
See Remarks
Sold, plan not stated
1,725
$15.59K
16.3%
21 decisions on file.